H2-K1-KO Mouse
Common Name
H2-K1-KO
제품 ID
S-KO-20339
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-14972-H2-K1-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “H2-K1-KO Mouse (카탈로그 번호 S-KO-20339)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
H2-K1-KO
품종 계통계통 ID
KOCMP-14972-H2-K1-B6J-VB
유전자명
제품 ID
S-KO-20339
유전자 별칭
K-f, H-2K, H2-K, H2-D1, H-2K(d)
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 17
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000025181
NCBI 전사체 ID
NM_001001892
타겟 영역
Exon 1~3
유효 영역 크기
~1.7 kb
유전자 연구 개요
H2-K1 is a gene encoding a major histocompatibility complex class I (MHC-I) molecule in mice. MHC-I molecules play a crucial role in the immune system by presenting peptide antigens to cytotoxic T cells, thus facilitating immune surveillance against infected or cancerous cells. They are also involved in the regulation of immune responses [2,4-7]. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, are valuable tools for studying H2-K1 function.
In lung injury research, a subpopulation of club-like lineage-negative epithelial progenitors marked by high H2-K1 expression was found to be critical for alveolar repair. These quiescent H2-K1high cells have in vitro regenerative activity of airway lineages, and after bleomycin injury, they expand and differentiate in vivo to alveolar lineages, though injured cells eventually show impaired self-renewal [1].
In cancer research, engineering an inducible affinity tag into the H2-K1 gene enabled isolation of MHC-I peptides from pancreatic and lung adenocarcinomas in vivo, helping to decipher the immunopeptidome and discover new tumor antigens [2]. In leukemia, H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance [3].
In Alzheimer's disease and aging studies, microglial H2-K1 expression was found to increase with age and in AD mouse models and human AD data, suggesting an association with cellular senescence [4].
In colon cancer, IL11/STAT3 signaling downregulates H2-K1 expression, and its inhibition increases H2-K1 expression and CD8+ T cell infiltration [5]. In aggressive cancers, VSIG4+ tumor-associated macrophages with VSIG4 deficiency show recovered H2-k1-mediated antigen presentation and activated antigen-specific CD8+ T cells [6].
In melanoma and breast cancer models, deletion of Ndufs4 (a mitochondrial respiratory complex I subunit) induces H2-K1 expression, restricting tumor growth and increasing T cell surveillance [7].
In cerebral infection with Toxoplasma gondii, IFN-γ produced by brain-resident cells upregulates H2-K1 expression, facilitating protective T cell immunity [8].
In conclusion, H2-K1 is essential for immune-related functions, including antigen presentation and immune surveillance. Studies using KO or CKO mouse models have revealed its roles in various disease conditions such as lung injury, cancer, Alzheimer's disease, and cerebral infections. Understanding H2-K1 function provides insights into disease mechanisms and potential therapeutic strategies.
References:
1. Kathiriya, Jaymin J, Brumwell, Alexis N, Jackson, Julia R, Tang, Xiaodan, Chapman, Harold A. 2020. Distinct Airway Epithelial Stem Cells Hide among Club Cells but Mobilize to Promote Alveolar Regeneration. In Cell stem cell, 26, 346-358.e4. doi:10.1016/j.stem.2019.12.014. https://pubmed.ncbi.nlm.nih.gov/31978363/
2. Jaeger, Alex M, Stopfer, Lauren E, Ahn, Ryuhjin, White, Forest M, Jacks, Tyler. 2022. Deciphering the immunopeptidome in vivo reveals new tumour antigens. In Nature, 607, 149-155. doi:10.1038/s41586-022-04839-2. https://pubmed.ncbi.nlm.nih.gov/35705813/
3. Ghosh, Somadri, Rodriguez-Zabala, Maria, Dushime, Gladys Telliam, Sitnicka, Ewa, Järås, Marcus. 2025. H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance. In Haematologica, , . doi:10.3324/haematol.2024.286468. https://pubmed.ncbi.nlm.nih.gov/39844759/
4. Kellogg, Collyn M, Pham, Kevin, Machalinski, Adeline H, Ocañas, Sarah R, Freeman, Willard M. 2023. Microglial MHC-I induction with aging and Alzheimer's is conserved in mouse models and humans. In GeroScience, 45, 3019-3043. doi:10.1007/s11357-023-00859-6. https://pubmed.ncbi.nlm.nih.gov/37393197/
5. Xiong, Wenjun, Chen, Yuehong, Zhang, Chaoting, Shi, Zhimin, Mou, Tingyu. 2023. Pharmacologic inhibition of IL11/STAT3 signaling increases MHC-I expression and T cell infiltration. In Journal of translational medicine, 21, 416. doi:10.1186/s12967-023-04079-6. https://pubmed.ncbi.nlm.nih.gov/37365574/
6. Pan, Zongfu, Chen, Jinming, Xu, Tong, Ge, Minghua, Huang, Ping. 2025. VSIG4+ tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1. In Journal of experimental & clinical cancer research : CR, 44, 45. doi:10.1186/s13046-025-03303-z. https://pubmed.ncbi.nlm.nih.gov/39920772/
7. Liang, Jiaxin, Vitale, Tevis, Zhang, Xixi, Wucherpfennig, Kai W, Puigserver, Pere. 2025. Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4/6 causes tumor immunogenicity. In Nature cancer, 6, 323-337. doi:10.1038/s43018-024-00895-x. https://pubmed.ncbi.nlm.nih.gov/39824999/
8. Suzuki, Yasuhiro, Lutshumba, Jenny, Chen, Kuey Chu, Sa, Qila, Ochiai, Eri. 2023. IFN-γ production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with Toxoplasma gondii. In Frontiers in cellular and infection microbiology, 13, 1110508. doi:10.3389/fcimb.2023.1110508. https://pubmed.ncbi.nlm.nih.gov/36875520/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
